Private-label potential ARKRAY USA manufactures private-label blood glucose meters for major retailers, signaling opportunities to expand white-label partnerships, private-label device collaborations, and OEM opportunities with other large retailers or pharmacy chains.

Diabetes care portfolio With a history of HbA1c analyzers, glucose monitoring systems, and clinical chemistry equipment, there are cross-sell opportunities to clinics, long-term care facilities, and hospitals seeking integrated diabetes management solutions.

Channel partnerships Recent collaborations with Rimidi and others suggest openness to clinical workflow platforms; leverage partnerships to bundle devices with digital health platforms, telemedicine services, and patient management software.

Healthcare training ARKRAY emphasizes personalized training and ongoing support, creating sales angles around installation, user training, and ongoing service plans to drive higher adoption, retention, and consumable replenishment.

Growth readiness Moderate US footprint (51-200 employees) and revenue in the lower-mid tens of millions indicate room to scale through expanded direct sales, private-label programs, and larger healthcare facility contracts, including long-term care and acute care markets.